Announcements Trials

Browse Landscape

Status

Active not recruiting 2 Recruiting 1 Not yet recruiting 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

balstilimab 2 3-Iodobenzylguanidine 2 zolbetuximab 1 zipalertinib 1 venetoclax 1 ulixertinib 1 tisagenlecleucel 1 tipifarnib 1 talazoparib 1 selinexor 1 ruxolitinib 1 ribociclib 1 nirogacestat 1 mirdametinib 1 mifamurtide 1 lifileucel 1 leronlimab 1 idecabtagene vicleucel 1 fluorodopa F 18 1 fluorocholine 1 dodecyl maltoside 1 carbon-11 methionine 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 asciminib 1 Sunitinib 1 Proton Pump Inhibitors 1 Peripheral Blood Stem Cell Transplantation 1 Methionine 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Available × zipalertinib × 1 year × Clear all

NCT07601399 2026-05-22

An EAP Treatment Protocol of Zipalertinib

Taiho Oncology, Inc.

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡